BACKGROUND: The goal of cardiac rehabilitation programs is not only to prolong life, but also to improve physical functioning, symptoms, wellbeing and health-related quality of life (HRQL). The aim of the study was to document short-term outcomes of cardiac rehabilitation programs in Austria. METHODS: Consecutive patients (N = 487, 64.7% male, age 60.9 +/- 12.5 SD years) after myocardial infarction (MI), with or without percutaneous interventions (PCI), coronary artery bypass grafting (CABG) or heart valve surgery (HVS), referred to the six inpatient rehabilitation centers of the Austrian PVA insurance company, were included in the study. Exercise capacity, risk factors and HRQL (MacNew Heart Disease Quality of Life Instrument [MacNew] and EuroQoL-5D [EQ-5D]) were measured at the beginning and end of the 4-week inpatient cardiac rehabilitation program. RESULTS: Global HRQL (MacNew) improved significantly over time in all patients combined (+0.75 +/- 0.88 SD, T = -16.99, df = 394, p < .001) and exceeded the minimal important difference. Patients with CABG, HVS or MI without PCI showed the greatest improvements in global HRQL after cardiac rehabilitation (p < .02). Blood pressure, cholesterol, triglyceride, body mass index, waist circumference improved significantly (all p < .001). CONCLUSION: These findings provide evidence that the improvements in HRQL and risk factors following cardiac rehabilitation in Austria are clinically important. HRQL should become a standard outcome parameter in cardiac rehabilitation.
BACKGROUND: The goal of cardiac rehabilitation programs is not only to prolong life, but also to improve physical functioning, symptoms, wellbeing and health-related quality of life (HRQL). The aim of the study was to document short-term outcomes of cardiac rehabilitation programs in Austria. METHODS: Consecutive patients (N = 487, 64.7% male, age 60.9 +/- 12.5 SD years) after myocardial infarction (MI), with or without percutaneous interventions (PCI), coronary artery bypass grafting (CABG) or heart valve surgery (HVS), referred to the six inpatient rehabilitation centers of the Austrian PVA insurance company, were included in the study. Exercise capacity, risk factors and HRQL (MacNew Heart Disease Quality of Life Instrument [MacNew] and EuroQoL-5D [EQ-5D]) were measured at the beginning and end of the 4-week inpatient cardiac rehabilitation program. RESULTS: Global HRQL (MacNew) improved significantly over time in all patients combined (+0.75 +/- 0.88 SD, T = -16.99, df = 394, p < .001) and exceeded the minimal important difference. Patients with CABG, HVS or MI without PCI showed the greatest improvements in global HRQL after cardiac rehabilitation (p < .02). Blood pressure, cholesterol, triglyceride, body mass index, waist circumference improved significantly (all p < .001). CONCLUSION: These findings provide evidence that the improvements in HRQL and risk factors following cardiac rehabilitation in Austria are clinically important. HRQL should become a standard outcome parameter in cardiac rehabilitation.
Authors: N Oldridge; G Guyatt; N Jones; J Crowe; J Singer; D Feeny; R McKelvie; J Runions; D Streiner; G Torrance Journal: Am J Cardiol Date: 1991-05-15 Impact factor: 2.778
Authors: L L Lim; L A Valenti; J C Knapp; A J Dobson; R Plotnikoff; N Higginbotham; R F Heller Journal: J Clin Epidemiol Date: 1993-11 Impact factor: 6.437
Authors: Brigitte Piso; Heinz Tüchler; Michael Gyimesi; Ingrid Kollmann; Gottfried Endel; Ingrid Wilbacher; Robert W Kurz; Rudolf Müller Journal: Wien Med Wochenschr Date: 2011-05
Authors: Stefan Höfer; Werner Kullich; Ursula Graninger; Manfred Wonisch; Alfred Gassner; Martin Klicpera; Herbert Laimer; Christiane Marko; Helmut Schwann; Rudolf Müller Journal: Health Qual Life Outcomes Date: 2009-12-08 Impact factor: 3.186
Authors: Matthew T D Dyer; Kimberley A Goldsmith; Linda S Sharples; Martin J Buxton Journal: Health Qual Life Outcomes Date: 2010-01-28 Impact factor: 3.186
Authors: Bach Xuan Tran; Mackenzie Pi Moir; Thao Phuong Thi Thai; Long Hoang Nguyen; Giang Hai Ha; Thu Hong Thi Nguyen; Nu Thi Truong; Carl A Latkin Journal: Biomed Res Int Date: 2018-09-26 Impact factor: 3.411